Inventor
Karl Schoenafinger
Inventor
Alzenau, DE
Overview
Patents· 55 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07CAcyclic or carbocyclic compounds10%
A61KPreparations for medical, dental or toiletry purposes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
9,079,906'Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20158,871,798'Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors'20148,853,206'Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments'20148,598,177'Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20138,466,169'SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments'20138,344,004'Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals'20138,247,452'Urea- and urethane-substituted acylureas, process for their preparation and their use'20128,236,810'Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV'20128,198,272'Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments'20128,173,674'Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals'20128,163,774'Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments'20128,138,207'Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions'20128,076,336'Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20118,003,668'Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders'20117,968,546'Pyridazinone kinase inhibitors'20117,910,612'4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use'20117,888,343'Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase'20117,879,864'Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes'20117,858,647'N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use'20107,838,528'Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use'20107,795,445'Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use'20107,781,613'Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments'20107,781,459'Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments'20107,772,257'Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use'20107,754,713'4-benzimidazol-2-ylpyridazin-3-one derivatives'20107,732,440'Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals'20107,727,989'4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments'20107,713,963'Acylated indanyl amines and their use as pharmaceuticals'20107,709,466'Pyridazinone derivatives, methods for their production and their use as pharmaceuticals'20107,683,181'Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof'20107,612,104'Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use'20097,569,700'Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments'20097,507,734'Pyridazinone derivatives'20097,501,440'Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use'20097,470,689'4-benzimidazol-2-ylpyridazin-3-one derivatives'20087,378,440'Substituted benzoylureido-o-benzoylamides, process for their preparation and their use'20087,351,703'Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators'20087,262,220'Urea- and urethane-substituted acylureas, process for their preparation and their use'20077,223,796'Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use'20077,196,114'Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use'20077,179,941'Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use'20077,138,398'Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them'20067,138,414'Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals'20067,094,800'Cyanopyrrolidides, process for their preparation and their use as medicaments'20067,078,404'Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use'20067,049,341'N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use'20067,008,957'Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments'20066,900,233'Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof'20056,844,347'Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same'20056,809,089'Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators'20046,627,628'Substituted 4-amino-2-aryl-cyclopentadpyrimidines, their production and use and pharmaceutical preparations containing same'20036,596,742'Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments'20036,548,547'Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators'20036,369,088'Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals'20026,344,468'Substituted isoindolones and their use as cyclic GMP modulators in medicaments'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2006Patents assigned to AVENTIS PHARMA GMBH (9)· patent assignee history
2002–2015Based in Alzenau, DE· patent location history
2006–2012Patents assigned to SANOFI AVENTIS DEUTSCHLAND (21)· patent assignee history
2009–2012Patents assigned to SANOFI AVENTIS (15)· patent assignee history
2010Based in Frankfurt am Main, DE· patent location history
2011–2015Patents assigned to SCHOENAFINGER KARL (12)· patent assignee history
2011–2015Patents assigned to HEINELT UWE (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SANOFI AVENTIS DEUTSCHLAND | 21 | 2006–2012 |
| SANOFI AVENTIS | 15 | 2009–2012 |
| SCHOENAFINGER KARLself | 12 | 2011–2015 |
| AVENTIS PHARMA GMBH | 9 | 2002–2006 |
| HEINELT UWE | 6 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Alzenau, DE | 54 | 2002–2015 |
| Frankfurt am Main, DE | 1 | 2010 |